Keyphrases
Respiratory Distress Syndrome
100%
Surfactant Protein A (SP-A)
100%
Neonatal Lung Disease
66%
Lung Disease
44%
Derangement
22%
Genome-wide Search
22%
Complementary DNA (cDNA)
17%
Prematurely Born Infants
16%
Pulmonary Surfactant
13%
Surfactant Protein B
13%
Normal Lung Function
11%
Genetic Factors
11%
Steroid Therapy
11%
Genetic Variants
11%
Specific Intent
11%
Surfactant Therapy
11%
Innate Host Defense
11%
High-throughput Methods
11%
Long-term Consequences
11%
Lung Function
11%
Treatment Therapy
11%
Splice Variant
11%
Physiologic
11%
Cis-acting Elements
11%
Trans-acting Factors
11%
Regulatory Mechanism
11%
Therapeutic Intervention
11%
Tag Single nucleotide Polymorphism (tSNP)
11%
Gene-gene
11%
Gestational Age
11%
Gene-environment Interaction
11%
Logistic Regression Analysis
11%
Bronchopulmonary Dysplasia
11%
Translational Regulation
11%
SNP Markers
11%
Host Defense
11%
Genetic Markers
11%
Overall Information
11%
Fetal Lung
11%
Cis-acting Factor
11%
Candidate Gene Study
11%
Infants at Risk
11%
Novel Therapies
11%
Treatment Course
11%
5′-untranslated Region (5′-UTR)
11%
Surfactant Protein A2
11%
Steroid Treatment
11%
Solid Foundation
11%
Evidence-based
11%
Targeted Therapy
11%
SNP Genotyping
11%
Chronic Lung Disease
11%
SNP
11%
Sequence Composition
11%
Environmental Factors
11%
Lipoproteins
9%
Lung
8%
Molecular Components
8%
Regulatory Studies
8%
Surfactant
5%
Biochemistry, Genetics and Molecular Biology
Surfactant Protein
100%
Candidate Gene
51%
Single Nucleotide Polymorphism
50%
Surfactant
42%
Intron
33%
Cis Acting Element
33%
Host Resistance
33%
Haplotype
24%
Complementary DNA
22%
Pulmonary Surfactant
18%
Surfactant Protein B
16%
Gene-Environment Interaction
16%
Trans-Acting Factor
16%
Single-Nucleotide Polymorphism
16%
Surfactant Protein A
16%
Genetic Divergence
16%
5' Untranslated Region
16%
Genotyping
16%
Dysplasia
16%
Translational Regulation
16%
Genetic Determinism
16%
Genetic Marker
16%
Drug Therapy
16%
Lipoprotein
12%
Molecular Cloning
11%
Allele
11%
Genetics
9%
DNA Probe
5%
Medicine and Dentistry
Silo-Filler's Disease
66%
Lung
35%
Single Nucleotide Polymorphism
29%
Pulmonary Disorder
22%
Complementary DNA
17%
Host Resistance
14%
Intron
14%
Pulmonary Surfactant
13%
Surfactant Associated Protein
8%
Lipoprotein
8%
Heredity
7%
Targeted Therapy
7%
Surfactant Therapy
7%
Drug Therapy
7%
Chronic Lung Disease
7%
Haplotype
7%
Steroid Therapy
7%
Surfactant Protein A
7%
Genotype Environment Interaction
7%
Steroid Treatment
7%
Logistic Regression Analysis
7%
Lung Dysplasia
7%
Environmental Factor
7%